Healthcare -
Biotechnology - NASDAQ - US
$ 1.1155
1.68 %
$ 33.7 M
Market Cap
-0.74
P/E
ANTX - CASH FROM OPERATIONS
Cash from Operations ANTX - AN2 Therapeutics, Inc.
-49.3 M
LAST VALUE
-21.33%
2 YEAR CAGR
-81.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR